Open access
3,841
Views
16
CrossRef citations to date
0
Altmetric
Articles
Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate
Xiao-Yu Zhanga Wuhan Institute of Biological Products, Co. Ltd, Wuhan, People’s Republic of ChinaView further author information
, Jing Guoa Wuhan Institute of Biological Products, Co. Ltd, Wuhan, People’s Republic of ChinaView further author information
, Xin Wana Wuhan Institute of Biological Products, Co. Ltd, Wuhan, People’s Republic of ChinaView further author information
, Jin-Ge Zhoua Wuhan Institute of Biological Products, Co. Ltd, Wuhan, People’s Republic of ChinaView further author information
, Wei-Ping Jina Wuhan Institute of Biological Products, Co. Ltd, Wuhan, People’s Republic of ChinaView further author information
, Jia Lua Wuhan Institute of Biological Products, Co. Ltd, Wuhan, People’s Republic of ChinaView further author information
, Wen-Hui Wanga Wuhan Institute of Biological Products, Co. Ltd, Wuhan, People’s Republic of ChinaView further author information
, An-Na Yanga Wuhan Institute of Biological Products, Co. Ltd, Wuhan, People’s Republic of ChinaView further author information
, Ding Xiang Liub South China Agricultural University, Guangdong Province Key Laboratory Microbial Signals & Disease Co, & Integrative Microbiology Research Center, Guangzhou, People’s Republic of ChinaView further author information
, Zheng-Li Shic Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People’s Republic of Chinahttps://orcid.org/0000-0001-8089-163XView further author information
, Zhi-Ming Yuanc Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
, Xin-Guo Lia Wuhan Institute of Biological Products, Co. Ltd, Wuhan, People’s Republic of ChinaView further author information
, Sheng-Li Menga Wuhan Institute of Biological Products, Co. Ltd, Wuhan, People’s Republic of ChinaView further author information
, Kai Duana Wuhan Institute of Biological Products, Co. Ltd, Wuhan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
, View further author information
Ze-Jun Wanga Wuhan Institute of Biological Products, Co. Ltd, Wuhan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
, View further author information
Xiao-Ming Yangd China National Biotech Group Company Ltd, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
& View further author information
Shuo Shena Wuhan Institute of Biological Products, Co. Ltd, Wuhan, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0003-0916-053XView further author information
show allhttps://orcid.org/0000-0003-0916-053XView further author information
Pages 2653-2662
|
Received 30 Sep 2020, Accepted 22 Nov 2020, Published online: 14 Dec 2020
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.